For in vitro diagnostic use. Others Elecsys HBsAg II IVD Elecsys® HBsAg II CPS_000478 08814856160 HBsAg G2 Elecsys cobas e 100 V2 Elecsys HBsAg II 07613336198285 Reagents, kits 100 tests cobas e 411/601/602 true 08814864160 HBsAg G2 Elecsys cobas e 200 V2 Elecsys HBsAg II 07613336198278 Reagents, kits 200 tests cobas e 411/601/602 true 04687787190 HBsAg G2 Elecsys cobas e 100 Elecsys HBsAg II 04015630921690 Reagents, kits 100 tests cobas e 411/601/602 true 08814856190 HBsAg G2 Elecsys cobas e 100 V2 Elecsys HBsAg II 07613336166840 Reagents, kits 100 tests cobas e 411/601/602 true 08814848190 HBsAg G2 Elecsys E2G 300 V2 Elecsys HBsAg II 07613336168103 Reagents, kits 300 tests cobas e 402/801 true 08814848192 HBsAg G2 Elecsys E2G 20x300 Elecsys HBsAg II 07613336223772 Reagents, kits 20 x 300 tests cobas e 402/801 true 07251076190 HBsAg G2 Elecsys E2G 300 Elecsys HBsAg II 04015630940028 Reagents, kits 300 tests cobas e 402/801 false 08814864190 HBsAg G2 Elecsys cobas e 200 V2 Elecsys HBsAg II 07613336166857 Reagents, kits 200 tests cobas e 411/601/602 true 08814856501 Elecsys HBsAg II en 3 FF000000052D9C0E FF00000004271A0E 08814856160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of hepatitis B surface antigen (HBsAg) in human adult and pediatric (2 to 21 years of age) serum and plasma (sodium heparin, lithium heparin, K2‑EDTA, sodium citrate). Assay results, in conjunction with other serological and clinical information, may be used for the laboratory diagnosis of individuals at risk for infection with HBV or with signs and symptoms of hepatitis. In addition, this assay may be used to screen for hepatitis B infection in pregnant women to identify neonates at high risk of acquiring HBV during the perinatal period.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e immunoassay analyzers. en 08814864501 Elecsys HBsAg II en 2 FF000000054D600E FF00000004271B0E 08814864160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of hepatitis B surface antigen (HBsAg) in human adult and pediatric (2 to 21 years of age) serum and plasma (sodium heparin, lithium heparin, K2‑EDTA, sodium citrate). Assay results, in conjunction with other serological and clinical information, may be used for the laboratory diagnosis of individuals at risk for infection with HBV or with signs and symptoms of hepatitis. In addition, this assay may be used to screen for hepatitis B infection in pregnant women to identify neonates at high risk of acquiring HBV during the perinatal period.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e immunoassay analyzers. en 04687787500 Elecsys HBsAg II en 19 FF00000004B2ED0E FF0000000017EA0E 04687787190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B surface antigen (HBsAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 08814856500 Elecsys HBsAg II en 4 FF0000000606E20E FF000000039B5D0E 08814856190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B surface antigen (HBsAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08814848500 Elecsys HBsAg II en 1 FF000000039B5A0E FF000000039B5A0E 08814848190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B surface antigen (HBsAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 08814848501 Elecsys HBsAg II en 3 FF000000052DB60E FF0000000420BF0E 08814848190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of hepatitis B surface antigen (HBsAg) in human adult and pediatric (2 to 21 years of age) serum and plasma (sodium heparin, lithium heparin, K2‑EDTA, sodium citrate). Assay results, in conjunction with other serological and clinical information, may be used for the laboratory diagnosis of individuals at risk for infection with HBV or with signs and symptoms of hepatitis. In addition, this assay may be used to screen for hepatitis B infection in pregnant women to identify neonates at high risk of acquiring HBV during the perinatal period.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08814848500 Elecsys HBsAg II en 3 FF0000000434320E FF000000035B7B0E 08814848190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B surface antigen (HBsAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08814848501 Elecsys HBsAg II en 4 FF00000006202B0E FF00000006202A0E 08814848190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of hepatitis B surface antigen (HBsAg) in human adult and pediatric (2 to 21 years of age) serum and plasma (sodium heparin, lithium heparin, K2‑EDTA, sodium citrate). Assay results, in conjunction with other serological and clinical information, may be used for the laboratory diagnosis of individuals at risk for infection with HBV or with signs and symptoms of hepatitis. In addition, this assay may be used to screen for hepatitis B infection in pregnant women to identify neonates at high risk of acquiring HBV during the perinatal period.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08814848501 Elecsys HBsAg II en 1 FF0000000420BF0E FF0000000420BE0E 08814848190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of hepatitis B surface antigen (HBsAg) in human adult and pediatric (2 to 21 years of age) serum and plasma (sodium heparin, lithium heparin, K2‑EDTA, sodium citrate). Assay results, in conjunction with other serological and clinical information, may be used for the laboratory diagnosis of individuals at risk for infection with HBV or with signs and symptoms of hepatitis. In addition, this assay may be used to screen for hepatitis B infection in pregnant women to identify neonates at high risk of acquiring HBV during the perinatal period.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08814848500 Elecsys HBsAg II en 4 FF00000004E6570E FF0000000434320E 08814848190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B surface antigen (HBsAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08814848503 Elecsys HBsAg II en 1 FF00000006403D0E FF000000061EFE0E 08814848192 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B surface antigen (HBsAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08814848503 Elecsys HBsAg II en 2 FF0000000657A90E FF00000006403D0E 08814848192 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B surface antigen (HBsAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07251076500 Elecsys HBsAg II en 2 FF000000030E9D0E FF00000001AE7E0E 07251076190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B surface antigen (HBsAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07251076501 Elecsys HBsAg II en 1 FF0000000256D50E FF0000000256D50E 07251076190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of hepatitis B surface antigen (HBsAg) in human adult and pediatric (2 to 21 years of age) serum and plasma (sodium heparin, lithium heparin, K2‑EDTA, sodium citrate). Assay results, in conjunction with other serological and clinical information, may be used for the laboratory diagnosis of individuals at risk for infection with HBV or with signs and symptoms of hepatitis. In addition, this assay may be used to screen for hepatitis B infection in pregnant women to identify neonates at high risk of acquiring HBV during the perinatal period.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08814864500 Elecsys HBsAg II en 4 FF000000060A3B0E FF000000039B670E 08814864190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B surface antigen (HBsAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en